The Optimal Sequential Therapy After Long Term Denosumab Treatment

PHASE4RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 20, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Osteoporosis
Interventions
DRUG

Alendronate

On time Zoledronate: Zoledronate would be given (one dose for one year) after the completiong of denosumab on time Alendronate and Zoledronate: Alendronate would be given one month before the the completiong of denosumab and the following 3 months (Total four months). After the completion of Alendronate, Zoledronate would be given (one dose).

Trial Locations (1)

640

RECRUITING

National Taiwan University Hospital, Yunlin branch, Douliu

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER